Seroatlas · Human Serome Atlas

ME2

NAD-dependent malic enzyme, mitochondrial

Also known as: MAOM_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P23368
Gene
ME2
Ensembl
ENSG00000082212
Chromosome
18
Canonical length
584 aa
Protein class
Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
Subcellular location
Mitochondria
Quaternary structure
Homotetramer

OverviewNCBI Gene

This gene encodes a mitochondrial NAD-dependent malic enzyme, a homotetrameric protein, that catalyzes the oxidative decarboxylation of malate to pyruvate. It had previously been weakly linked to a syndrome known as Friedreich ataxia that has since been shown to be the result of mutation in a completely different gene. Certain single-nucleotide polymorphism haplotypes of this gene have been shown to increase the risk for idiopathic generalized epilepsy. Alternatively spliced transcript variants encoding different isoforms found for this gene. [provided by RefSeq, Dec 2009]

Canonical amino-acid sequenceUniProt

584 residues, UniProt reviewed canonical sequence.

>P23368|ME2
     1  MLSRLRVVST TCTLACRHLH IKEKGKPLML NPRTNKGMAF TLQERQMLGL QGLLPPKIET
    61  QDIQALRFHR NLKKMTSPLE KYIYIMGIQE RNEKLFYRIL QDDIESLMPI VYTPTVGLAC
   121  SQYGHIFRRP KGLFISISDR GHVRSIVDNW PENHVKAVVV TDGERILGLG DLGVYGMGIP
   181  VGKLCLYTAC AGIRPDRCLP VCIDVGTDNI ALLKDPFYMG LYQKRDRTQQ YDDLIDEFMK
   241  AITDRYGRNT LIQFEDFGNH NAFRFLRKYR EKYCTFNDDI QGTAAVALAG LLAAQKVISK
   301  PISEHKILFL GAGEAALGIA NLIVMSMVEN GLSEQEAQKK IWMFDKYGLL VKGRKAKIDS
   361  YQEPFTHSAP ESIPDTFEDA VNILKPSTII GVAGAGRLFT PDVIRAMASI NERPVIFALS
   421  NPTAQAECTA EEAYTLTEGR CLFASGSPFG PVKLTDGRVF TPGQGNNVYI FPGVALAVIL
   481  CNTRHISDSV FLEAAKALTS QLTDEELAQG RLYPPLANIQ EVSINIAIKV TEYLYANKMA
   541  FRYPEPEDKA KYVKERTWRS EYDSLLPDVY EWPESASSPP VITE

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against ME2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.23
Highest tissue expression
86 nTPM

Expression across tissuesHPA

Tissue

  • choroid plexus: 86 nTPM
  • heart muscle: 42 nTPM
  • duodenum: 36 nTPM
  • rectum: 30 nTPM
  • small intestine: 30 nTPM
  • parathyroid gland: 30 nTPM

Single-cell type

  • choroid plexus epithelial cells: 393 nCPM
  • rod photoreceptor cells: 299 nCPM
  • kupffer cells: 289 nCPM
  • thymic myoid cells: 248 nCPM
  • neutrophil progenitors: 212 nCPM
  • neutrophils: 185 nCPM

Immune cell

  • non-classical monocyte: 26 nTPM
  • eosinophil: 21 nTPM
  • intermediate monocyte: 19 nTPM
  • neutrophil: 18 nTPM
  • classical monocyte: 16 nTPM
  • myeloid DC: 13 nTPM

Brain region

  • choroid plexus: 108 nTPM
  • pons: 24 nTPM
  • midbrain: 24 nTPM
  • thalamus: 23 nTPM
  • medulla oblongata: 23 nTPM
  • hypothalamus: 22 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about ME2.

Disease | GeneticClinVar

1 pathogenic / likely-pathogenic of 105 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.06
gnomAD pLI
0
gnomAD missense Z
0.97
DepMap mean gene effect
-0.04
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads ME2 as an antibody target. Whether an autoantibody or antibody against ME2 could matter depends on whether native ME2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

ME2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label ME2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/ME2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...